Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3401545
Max Phase: Preclinical
Molecular Formula: C18H13NO2
Molecular Weight: 275.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3401545
Max Phase: Preclinical
Molecular Formula: C18H13NO2
Molecular Weight: 275.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(/C=C/c1ccc2ccccc2n1)c1ccccc1O
Standard InChI: InChI=1S/C18H13NO2/c20-17-8-4-2-6-15(17)18(21)12-11-14-10-9-13-5-1-3-7-16(13)19-14/h1-12,20H/b12-11+
Standard InChI Key: BWMOQTVQVZYKLI-VAWYXSNFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 275.31 | Molecular Weight (Monoisotopic): 275.0946 | AlogP: 3.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.19 | CX Basic pKa: 3.87 | CX LogP: 4.63 | CX LogD: 4.22 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.58 | Np Likeness Score: -0.25 |
1. Radhakrishnan SK, Shimmon RG, Conn C, Baker AT.. (2015) Azachalcones: a new class of potent polyphenol oxidase inhibitors., 25 (8): [PMID:25782744] [10.1016/j.bmcl.2015.02.060] |
2. (2013) Family of PFKFB3 inhibitors with anti-neoplastic activities, |
Source(2):